journal article·2019-09

Nanotopographical regulation of pancreatic islet-like cluster formation from human pluripotent stem cells using a gradient-pattern chip

Jong Hyun Kim, Bo Gi Park, Suel-Kee Kim, Dong-Hyun Lee, Gyung Gyu Lee, Deok-Ho Kim, Byung-Ok Choi, Kyu Back Lee, Jong-Hoon Kim

Acta Biomaterialia· Volume 95
Publisher page

Abstract

Bioengineering approaches to regulate stem cell fates aim to recapitulate the in vivo microenvironment. In recent years, manipulating the micro- and nano-scale topography of the stem cell niche has gained considerable interest for the purposes of controlling extrinsic mechanical cues to regulate stem cell fate and behavior in vitro. Here, we established an optimal nanotopographical system to improve 3-dimensional (3D) differentiation of pancreatic cells from human pluripotent stem cells (hPSCs) by testing gradient-pattern chips of nano-scale polystyrene surface structures with varying sizes and shapes. The optimal conditions for 3D differentiation of pancreatic cells were identified by assessing the expression of developmental regulators that are required for pancreatic islet development and maturation. Our results showed that the gradient chip of pore-part 2 (Po-2, 200-300 nm diameter) pattern was the most efficient setting to generate clusters of pancreatic endocrine progenitors (PDX1+ and NGN3+) compared to those of other pore diameters (Po-1, 100-200 or Po-3, 300-400 nm) tested across a range of pillar patterns and flat surfaces. Furthermore, the Po-2 gradient pattern-derived clusters generated islet-like 3D spheroids and tested positive for the zinc-chelating dye dithizone. The spheroids consisted of more than 30% CD200 + endocrine cells and also expressed NKX6.1 and NKX2.2. In addition, pancreatic β- cells expressing insulin and polyhormonal cells expressing both insulin and glucagon were obtained at the final stage of pancreatic differentiation. In conclusion, our data suggest that an optimal topographical structure for differentiation to specific cell types from hPSCs can be tested efficiently by using gradient-pattern chips designed with varying sizes and surfaces. STATEMENT OF SIGNIFICANCE: Our study provides demonstrates of using gradient nanopatterned chips for differentiation of pancreatic islet-like clusters. Gradient nanopatterned chips are consisted of two different shapes (nanopillar and nanopore) in three different ranges of nano sizes (100-200, 200-300, 300-400 nm). We found that optimal nanostructures for differentiation of pancreatic islet-like clusters were 200-300 nm nano pores. Cell transplantation is one of the major therapeutic option for type 1 diabetes mellitus (DM) using stem cell-derived β-like cells. We generated 50 um pancreatic islet-like clusters in size, which would be an optimal size for cell transplantation. Futuremore, the small clusters provide a powerful source for cell therapy. Our findings suggest gradient nanopatterned chip provides a powerful tool to generate specific functional cell types of a high purity for potential uses in cell therapy development.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Pancreatic function and diabetes · Electrohydrodynamics and Fluid Dynamics · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. Matrix nanotopography as a regulator of cell function10.1083/jcb.201108062 ↗
2. How cells respond to environmental cues - insights from bio-functionalized substrates
3. Engineering substrate topography at the micro- and nanoscale to control cell function10.1002/anie.200805179 ↗
4. Biophysical regulation of cell behavior-cross talk between substrate stiffness and nanotopography
5. A. Fabienna, L. Oliver, Biophysical Properties of the Basal Lamina: A Highly Selective Extracellular Matrix, 2016
6. Extracellular matrix: a dynamic microenvironment for stem cell niche10.1016/j.bbagen.2014.01.010 ↗
7. Nanotopographical control for maintaining undifferentiated human embryonic stem cell colonies in feeder free conditions10.1016/j.biomaterials.2013.10.031 ↗
8. Engineering cell-material interfaces for long-term expansion of human pluripotent stem cells10.1016/j.biomaterials.2012.10.020 ↗
9. Stem cell migration and mechanotransduction on linear stiffness gradient hydrogels10.1073/pnas.1618239114 ↗
10. Stem cell fate dictated solely by altered nanotube dimension10.1073/pnas.0813200106 ↗
11. Nanotopography modulates mechanotransduction of stem cells and induces differentiation through focal adhesion kinase10.1021/nn304966z ↗
12. Nanotopography promotes pancreatic differentiation of human embryonic stem cells and induced pluripotent stem cells10.1021/acsnano.5b06985 ↗
13. Effects of SiO2 micropillar arrays on endothelial cells’ morphology10.1016/j.nbt.2016.07.002 ↗
14. Mass-producible nano-featured polystyrene surfaces for regulating the differentiation of human adipose-derived stem cells10.1002/mabi.201200225 ↗
15. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease10.1038/nature00900 ↗
16. Pancreatic islet-like three-dimensional aggregates derived from human embryonic stem cells ameliorate hyperglycemia in streptozotocin-induced diabetic mice10.3727/096368914X685438 ↗
17. Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes10.1007/s10565-017-9392-y ↗
18. Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro10.15252/embj.201591058 ↗
19. A scalable system for production of functional pancreatic progenitors from human embryonic stem cells10.1371/journal.pone.0037004 ↗
20. Endodermal differentiation of human pluripotent stem cells to insulin-producing cells in 3D culture10.1038/srep04488 ↗
21. In Vitro Differentiation of Pluripotent Stem Cells into Functional beta Islets Under 2D and 3D Culture Conditions and In Vivo Preclinical Validation of 3D Islets10.1007/7651_2015_230 ↗
22. Heterogeneous differentiation of human mesenchymal stem cells in response to extended culture in extracellular matrices10.1089/ten.tea.2008.0603 ↗
23. Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed10.1634/stemcells.2006-0219 ↗
24. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells10.1073/pnas.0603916103 ↗
25. FGF4 and retinoic acid direct differentiation of hESCs into PDX1-expressing foregut endoderm in a time- and concentration-dependent manner10.1371/journal.pone.0004794 ↗
26. Vertebrate endoderm development and organ formation10.1146/annurev.cellbio.042308.113344 ↗
27. Pdx1 and Ngn3 overexpression enhances pancreatic differentiation of mouse ES cell-derived endoderm population10.1371/journal.pone.0024058 ↗
28. Pancreatic neurogenin 3-expressing cells are unipotent islet precursors10.1242/dev.039214 ↗
29. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells10.1038/nbt1259 ↗
30. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells10.1038/nbt.1931 ↗
31. Nkx2.2 regulates beta-cell function in the mature islet10.2337/db06-1766 ↗
32. Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells10.1016/j.scr.2015.01.007 ↗
33. Generation of insulin-secreting islet-like clusters from human skin fibroblasts10.1074/jbc.M806597200 ↗
34. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis10.1242/dev.102.4.639 ↗
35. Pancreatic islet-like clusters from periosteum-derived progenitor cells10.1007/s12257-013-0005-1 ↗
36. Endocrine cell clustering during human pancreas development10.1369/jhc.2009.953307 ↗
37. Islet architecture: A comparative study10.4161/isl.1.2.9480 ↗
38. Superiority of small islets in human islet transplantation10.2337/db06-0779 ↗
39. Immunohistochemical characterisation of cells co-producing insulin and glucagon in the developing human pancreas10.1007/s00125-011-2344-9 ↗